Florida cancer specialists & Research Institute

Florida City, Florida 33401

0 studies enrolling now · 1 studies all time

What they study most

Non Hodgkin Lymphoma

Studies at this site

• Efficacy and Safety Study of Tenalisib (RP6530), a Novel PI3K δ/γ Dual Inhibitor in Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (iNHL) — Completed